About the Journal

Antibody Reports (eISSN 2624-8557) is an international, academic open-access online journal edited by the "Geneva Antibody Facility". It is dedicated to focusing on the technical and experimental validation of recombinant antibodies. Our primary goal is to encourage scientists to publish their experimental results, thereby generating better and more reproducible data in a collaborative manner and promoting the utilization of recombinant antibodies.

Focus and Scope

Antibody Reports (ISSN 2624-8557) focuses on experimental validation of recombinant antibodies. The general aim is to define the specificity of an antibody and which detection techniques it is compatible with. Negative results, when including an adequate positive control, are also valuable. We encourage scientists to publish their experimental results in as much detail as possible, with the philosophy of "one antigen, one technique, one paper".

Open Access Policy

This journal is purely open access and provides immediate access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Publishing Schedule

Antibody Reports aims to maintain a continuous publication schedule, ensuring that articles are promptly published online as soon as they are ready, with the goal of achieving a rapid release, potentially on a daily basis.

Archiving Policy

This journal ensures the long-term availability of its contents. Articles published in Antibody Reports are automatically deposited in the institutional repository of the University of Geneva, and from there, in the SAFE Private LOCKSS Network managed by 7 universities located on multiple continents, thus ensuring a very high level of preservation.
Antibody reports also encourages the self-archiving of articles after publication by their authors in open-access repositories of their choice, whether it is the submitted version, the accepted version, or the published version of the contribution.

Copyright Notice

Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the journal. By virtue of their appearance in this open access journal, articles are free to use after initial publication under the Creative Commons Attribution 4.0 International licence (CC-BY).

Publisher

This journal is published by the Geneva antibody facility with the support of  the Open Access Publication Service of the University of Geneva.